TargetMuscarinic acetylcholine receptor M1(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataKi: 341nMAssay Description:Inhibition of muscarinic acetylcholine receptor M1 (unknown origin)More data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M4(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataKi: 865nMAssay Description:Inhibition of muscarinic acetylcholine receptor M4 (unknown origin)More data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataKi: 4.01E+3nMAssay Description:Inhibition of muscarinic acetylcholine receptor M2 (unknown origin)More data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.240nMAssay Description:Antagonist activity against CCR2 in human PBMC assessed as inhibition of MCP1-induced chemotaxis at 37 degCMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Antagonist activity at CCR2 in human THP1 cells assessed as reduction in MCP1-induced chemotaxis measured after 30 mins by calcein-AM dye based fluor...More data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.400nMT: 2°CAssay Description:Inhibition of [125I]hMCP1 binding to CCR2 in human PBMC incubated for 30 mins at room temperatureMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Displacement of [125I]MCP1 from CCR2 in human PBMC measured after 30 minsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.450nMAssay Description:Antagonist activity against CCR2 in human PBMC assessed as inhibition of MCP1-induced chemotaxis at 37 degCMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.450nMAssay Description:Antagonist activity against CCR2 in human PBMC assessed as inhibition of MCP1-induced chemotaxis at 37 degCMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.5nMT: 2°CAssay Description:Inhibition of [125I]hMCP1 binding to CCR2 in human PBMC incubated for 30 mins at room temperatureMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Antagonist activity against CCR2 in human PBMC assessed as inhibition of MCP1-induced chemotaxis at 37 degCMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Antagonist activity against CCR2 in human PBMC assessed as inhibition of MCP1-induced chemotaxis at 37 degCMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Antagonist activity at CCR2 in human THP1 cells assessed as reduction in MCP1-induced chemotaxis measured after 30 mins by calcein-AM dye based fluor...More data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.670nMAssay Description:Inhibition of CCR2 in human THP1 cells assessed as reduction in MCP1-induced chemotaxis measured after 10 mins by calcein-AM dye based fluorescence a...More data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.700nMT: 2°CAssay Description:Inhibition of [125I]hMCP1 binding to CCR2 in human PBMC incubated for 30 mins at room temperatureMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Displacement of [125I]MCP1 from CCR2 in human PBMC measured after 30 minsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Antagonist activity at CCR2 in human THP-1 cells assessed as reduction in CCL2-induced chemotaxisMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Antagonist activity at CCR2 in human THP1 cells assessed as reduction in MCP1-induced chemotaxis measured after 30 mins by calcein-AM dye based fluor...More data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.800nMAssay Description:Antagonist activity at CCR2 in human THP1 cells assessed as reduction in MCP1-induced chemotaxis measured after 30 mins by calcein-AM dye based fluor...More data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.800nMAssay Description:Antagonist activity at CCR2 in human THP-1 cells assessed as reduction in CCL2-induced chemotaxisMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.800nMT: 2°CAssay Description:Inhibition of [125I]hMCP1 binding to CCR2 in human PBMC incubated for 30 mins at room temperatureMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.800nMT: 2°CAssay Description:Inhibition of [125I]hMCP1 binding to CCR2 in human PBMC incubated for 30 mins at room temperatureMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.800nMAssay Description:Antagonist activity at CCR2 in human THP-1 cells assessed as reduction in CCL2-induced chemotaxisMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:Displacement of [125I]MCP1 from CCR2 in human PBMC measured after 30 minsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1nMT: 2°CAssay Description:Inhibition of [125I]hMCP1 binding to CCR2 in human PBMC incubated for 30 mins at room temperatureMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 1(Homo sapiens (Human))
Bristol Myers Squibb Company
Curated by ChEMBL
Bristol Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Displacement of [125I]MIP-1alpha from CCR1 in human THP1 cellsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 1(Homo sapiens (Human))
Bristol Myers Squibb Company
Curated by ChEMBL
Bristol Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Displacement of [125I]MIP-1alpha from CCR1 in human THP1 cellsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Displacement of [125I]MCP1 from CCR2 in human PBMC measured after 30 minsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Displacement of [125I]MCP1 from CCR2 in human PBMC measured after 30 mins by Microscintillation counting analysisMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.10nMT: 2°CAssay Description:Inhibition of [125I]hMCP1 binding to CCR2 in human PBMC incubated for 30 mins at room temperatureMore data for this Ligand-Target Pair
Affinity DataIC50: 1.10nMAssay Description:Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisMore data for this Ligand-Target Pair
Affinity DataIC50: 1.10nMAssay Description:Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.30nMAssay Description:Displacement of [125I]MCP1 from CCR2 in human PBMC measured after 30 mins by Microscintillation counting analysisMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.30nMAssay Description:Antagonist activity against CCR2 in human PBMC assessed as inhibition of MCP1-induced chemotaxis at 37 degCMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.40nMAssay Description:Displacement of [125I]MCP1 from CCR2 in human PBMC measured after 30 minsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.60nMAssay Description:Antagonist activity at CCR2 in human THP1 cells assessed as reduction in MCP1-induced chemotaxis measured after 30 mins by calcein-AM dye based fluor...More data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.70nMAssay Description:Antagonist activity at CCR2 in human THP1 cells assessed as reduction in MCP1-induced chemotaxis measured after 30 mins by calcein-AM dye based fluor...More data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.70nMT: 2°CAssay Description:Inhibition of [125I]hMCP1 binding to CCR2 in human PBMC incubated for 30 mins at room temperatureMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.80nMAssay Description:Displacement of [125I]MCP1 from CCR2 in human PBMC measured after 30 minsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.80nMAssay Description:Antagonist activity against CCR2 in human PBMC assessed as inhibition of MCP1-induced chemotaxis at 37 degCMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.90nMAssay Description:Displacement of [125I]MCP1 from CCR2 in human PBMC measured after 30 minsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 1(Homo sapiens (Human))
Bristol Myers Squibb Company
Curated by ChEMBL
Bristol Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Displacement of [125I]MIP-1alpha from CCR1 in human THP1 cellsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 1(Homo sapiens (Human))
Bristol Myers Squibb Company
Curated by ChEMBL
Bristol Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Displacement of [125I]MIP-1alpha from CCR1 in human THP1 cellsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 1(Homo sapiens (Human))
Bristol Myers Squibb Company
Curated by ChEMBL
Bristol Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Displacement of [125I]MIP-1alpha from CCR1 in human THP1 cellsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 1(Homo sapiens (Human))
Bristol Myers Squibb Company
Curated by ChEMBL
Bristol Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Displacement of [125I]MIP-1alpha from CCR1 in human THP1 cellsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 1(Homo sapiens (Human))
Bristol Myers Squibb Company
Curated by ChEMBL
Bristol Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Displacement of [125I]MIP-1alpha from CCR1 in human THP1 cellsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 1(Homo sapiens (Human))
Bristol Myers Squibb Company
Curated by ChEMBL
Bristol Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Displacement of [125I]MIP-1alpha from CCR1 in human THP1 cellsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 1(Homo sapiens (Human))
Bristol Myers Squibb Company
Curated by ChEMBL
Bristol Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Displacement of [125I]MIP-1alpha from CCR1 in human THP1 cellsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 1(Homo sapiens (Human))
Bristol Myers Squibb Company
Curated by ChEMBL
Bristol Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Antagonist activity at CCR1 receptor in human THP1 cells assessed as inhibition of MIP-1alpha induced chemotaxis after 60 minsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 2.20nMT: 2°CAssay Description:Inhibition of [125I]hMCP1 binding to CCR2 in human PBMC incubated for 30 mins at room temperatureMore data for this Ligand-Target Pair
![](/img/powered_by_small.gif)